Issue 8/2009
Content (10 Articles)
Immune responses of TLR5+ lamina propria dendritic cells in enterobacterial infection
Satoshi Uematsu, Shizuo Akira
Asymmetrical circumferential distribution of esophagogastric junctional lesions: anatomical and physiological considerations
Yoshikazu Kinoshita, Kenji Furuta, Kyoichi Adachi, Yuji Amano
Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication
Katsunori Iijima, Tomoyuki Koike, Yasuhiko Abe, Nobuyuki Ara, Kaname Uno, Akira Imatani, Shuichi Ohara, Tooru Shimosegawa
The use of indigocarmine spray increases the colonoscopic detection rate of adenomas
Kazutomo Togashi, David G. Hewett, Graham L. Radford-Smith, Leo Francis, Barbara A. Leggett, Mark N. Appleyard
Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
Shuji Ishii, Shingo Tsuji, Masahiko Tsujii, Tsutomu Nishida, Kenji Watabe, Hideki Iijima, Tetsuo Takehara, Sunao Kawano, Norio Hayashi
Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction?
Chika Kusano, Tonya Kaltenbach, Taichi Shimazu, Roy Soetikno, Takuji Gotoda
The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation
Motoki Takashima, Christopher J. Parsons, Kenichi Ikejima, Sumio Watanabe, Eric S. White, Richard A. Rippe
Interferon-α-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway
Azusa Matsumoto, Tatsuki Ichikawa, Kazuhiko Nakao, Hisamitsu Miyaaki, Kumi Hirano, Masumi Fujimito, Motohisa Akiyama, Satoshi Miuma, Eisuke Ozawa, Hidetaka Shibata, Shigeyuki Takeshita, Hironori Yamasaki, Masanori Ikeda, Nobuyuki Kato, Katsumi Eguchi
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
Nao Kurashige, Kazuyoshi Ohkawa, Naoki Hiramatsu, Takayuki Yakushijin, Kiyoshi Mochizuki, Tsugiko Oze, Shinichi Kiso, Tatsuya Kanto, Tetsuo Takehara, Akinori Kasahara, Yoshinori Doi, Akira Yamada, Kazuto Fukuda, Masahide Oshita, Eiji Mita, Hiroyuki Fukui, Toshihiko Nagase, Harumasa Yoshihara, Yasuharu Imai, Michio Kato, Takeshi Kashihara, Norio Hayashi
Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B
Holger G. Hass, Thomas Bock, Oliver Nehls, Stephan Kaiser